David J. Drutz's most recent trade in Altimmune Inc was a trade of 21,750 Stock Options (option to buy) done . Disclosure was reported to the exchange on Aug. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 21,750 | 4,350 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 19 Aug 2024 | 21,750 | 63,708 (0%) | 0% | 2.5 | 54,375 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.60 per share. | 19 Aug 2024 | 20,000 | 49,785 (0%) | 0% | 2.6 | 52,000 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 20,000 | 0 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Sale of securities on an exchange or to another person at price $ 6.88 per share. | 19 Aug 2024 | 8,184 | 55,524 (0%) | 0% | 6.9 | 56,306 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Sale of securities on an exchange or to another person at price $ 6.93 per share. | 19 Aug 2024 | 7,827 | 41,958 (0%) | 0% | 6.9 | 54,241 | Common Stock, par value $0.0001 |
| Altimmune Inc | Drutz J. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 26,100 | 26,100 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 15 Aug 2023 | 300 | 29,785 (0%) | 0% | 2.9 | 863 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 23 Mar 2023 | 9,000 | 29,484 (0%) | 0% | 4.3 | 38,430 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 18 Nov 2022 | 139 | 20,151 (0%) | 0% | 2.4 | 334 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 139 | 0 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 15 Jun 2022 | 1,000 | 20,012 (0%) | 0% | 8 | 8,000 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 24 May 2022 | 1,200 | 19,012 (0%) | 0% | 4.5 | 5,400 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 139 | 139 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 139 | 139 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 139 | 0 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 14 Dec 2021 | 139 | 17,812 (0%) | 0% | 2.4 | 334 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 60 | 0 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 13 Nov 2020 | 60 | 17,603 (0%) | 0% | 2.4 | 144 | Common Stock, par value $0.0001 |
| Altimmune Inc | David J. Drutz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,500 | 25,500 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 16,850 | 0 | - | - | Restricted Stock Units ("RSUs") | |
| Altimmune Inc | David J. Drutz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 16,850 | 17,543 (0%) | 0% | 0 | Common Stock, par value $0.0001 |